Skip to main content
. 2022 Jun 8;221(7):e202108015. doi: 10.1083/jcb.202108015

Figure S1.

Figure S1.

ORF10 specifically stimulates CUL2ZYG11B activity. (A) ZYG11B could interact with ORF10. Purified ORF10-FLAG was used to pull down GST-ZYG11B. (B) ELOC could not bind with ORF10. Purified ORF10-FLAG was used to pull down 6 × His-ELOC-HA. (C) CUL2 could not interact with ORF10. Purified ORF10-FLAG was used to pull down CUL2-HA. (D) RBX1 could not bind with ORF10. Purified ORF10-FLAG was used to pull down 6 × His-RBX1-HA. (E) Reconstitution of the CUL2ZYG11B ubiquitination system. Either E1, E2, ZYG11B-CUL2 immunocomplex, or Ub were withheld from the CUL2ZYG11B ubiquitination system in vitro. The reaction products were detected by immunoblotting with anti-ubiquitin and FLAG antibodies. (F) ORF10 stimulates the ubiquitination activity of CUL2ZYG11B. Either ORF10 or BSA was added to the CUL2ZYG11B ubiquitination system in vitro, which contains E1, E2, ubiquitin, ATP and ZYG11B-CUL2 immunocomplex. The reaction products were detected by immunoblotting with anti-ubiquitin and FLAG antibodies. (G) ORF10 is essential for the stimulation of CUL2ZYG11B ubiquitination activity. Either E1, E2, ZYG11B-CUL2 immunocomplex, Ub or ORF10 were withheld from the CUL2ZYG11B ubiquitination system in vitro. The reaction products were detected by immunoblotting with anti-ubiquitin antibody. (H) VHL could not bind with ORF10. Purified ORF10-FLAG was used to pull down 6 × His-VHL-MYC. (I) ORF10 could not stimulate the ubiquitination activity of CUL2VHL. Either ORF10 or BSA was added to the CUL2VHL ubiquitination system in vitro, which contains E1, E2, ubiquitin, ATP, and CUL2VHL. The reaction products were detected by immunoblotting with anti-ubiquitin antibody. (J) ORF10 has no effect on the ubiquitination activity of CUL2VHL. Either ORF10 or BSA was added to the CUL2VHL ubiquitination system in vitro, which contains E1, E2, ubiquitin, ATP, and CUL2VHL. The reaction products were collected at the indicated times, and reaction products were detected by immunoblotting with anti-ubiquitin and FLAG antibodies. Source data are available for this figure: SourceData FS1.